Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Galena Will Adjourn Special Meeting until Friday, December 29, 2017, Urges Stockholders to Vote
Galena Biopharma, Inc. (NASDAQ:GALE), (“Galena”) announced today that its special meeting of stockholders (“Special Meeting”), scheduled for December 15, 2017, will be convened and adjourned, without... 
From GlobeNewswire News Releases
Galena Biopharma Reminds Shareholders to Vote Ahead of Special Meeting on December 15, 2017
Galena Biopharma, Inc. (NASDAQ: GALE) would like to remind stockholders to vote their respective shares and support the business combination transaction with SELLAS Life Sciences Group Ltd. To assist... 
From GlobeNewswire News Releases
Galena Biopharma Reports Third Quarter 2017 Financial Results
Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported its financial results for the quarter... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Galena Biopharma, Inc. - GALE
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Galena Biopharma,... 
From PR Newswire
Deadline on April 14 Upcoming in Lawsuit for Investors in Galena Biopharma Inc (NASDAQ:GALE)
San Diego, CA -- (SBWIRE) -- 04/07/2017 -- The Shareholders Foundation announces that a deadline is coming up on April 14, 2017 in the lawsuit filed for investors of Galena Biopharma Inc (NASDAQ:GALE)... 
From SBWire - Latest Press Releases
DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm
From ACCESSWIRE
Deadline Alert: GPM Reminds Investors of the April 14 Deadline in the Class Action Lawsuit Against Galena Biopharma, Inc.
Deadline Alert: GPM Reminds Investors of the April 14 Deadline in the Class Action Lawsuit Against Galena Biopharma, Inc. 
From Business Wire News Releases
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Galena Biopharma, Inc. (GALE) and Lead Plaintiff Deadline - April 14, 2017
From ACCESSWIRE
Investigation for Long-Term Investors in Shares of Galena Biopharma Inc (NASDAQ:GALE) Announced
San Diego, CA -- (SBWIRE) -- 03/23/2017 -- An investigation on behalf of current long-term investors in shares of Galena Biopharma Inc (NASDAQ:GALE) concerning potential breaches of fiduciary duties by... 
From SBWire - Latest Press Releases
SHAREHOLDR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
GALE STOCK LOSS: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of Important Deadline in Class Action – GALE
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Galena Biopharma, Inc. securities (NASDAQ:GALE) from August 11, 2014 through January 31, 2017, both dates inclusive (the “Class... 
From GlobeNewswire News Releases
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
Galena Biopharma Reports Fourth Quarter and Year End 2016 Financial Results and Provides a Corporate Update
Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported its financial results for the quarter... 
From GlobeNewswire News Releases
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017
Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Galena Biopharma, Inc. (“Galena” or the “Company”) (NASDAQ:GALE) and certain of its officers, and... 
From GlobeNewswire News Releases
EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
IMPORTANT GALENA BIOPHARMA, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the District of New Jersey against Galena
Lead Plaintiff Deadline is April 14, 2017 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
Investor Alert: Kaplan Fox Announces Investigation Of Galena Biopharma Inc.
Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Galena Biopharma, Inc. ("Galena" or the "Company") (NASDAQ: GALE). 
From PR Newswire
Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim Chief Executive Officer
Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced that the Company’s Board of Directors... 
From GlobeNewswire News Releases
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
From ACCESSWIRE
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Galena Biopharma Inc. (“Galena” or the “Company”) (Nasdaq: GALE) concerning possible violations of federal... 
From Business Wire News Releases
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Galena Biopharma, Inc. Investors and Encourages Investors to Contact the Firm
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Galena Biopharma, Inc. Investors and Encourages Investors to Contact the Firm 
From Business Wire News Releases
INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Galena Biopharma Inc. and Encourages Investors with Losses to Contact the Firm
Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Galena Biopharma Inc. (“Galena” or the “Company”) (Nasdaq: GALE) concerning... 
From Business Wire News Releases
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Galena Biopharma, Inc. (“Galena” or the “Company”) (NASDAQ:GALE) and... 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.